Bio-Reference Laboratories, Inc. Announces Q4 EPS of $.31

Bio-Reference Laboratories, Inc. BRLI announced best ever Company quarterly and annual fiscal year results. The Company recorded Q4FY10 revenues of $126,596,000 the best ever quarter in terms of revenues in corporate history and an increase of 24% over the $102,312,000 recorded in the fourth quarter, fiscal year 2009. Net income before taxes in Q4FY10 totaled $14,716,000; an increase of 15% compared with net income before taxes of $12,756,000 in Q4FY09. Net income after tax for Q4FY10 totaled $8,576,000 or $.31 per share as compared with $7,183 or $.26 per share in the corresponding quarter in FY09.